Lanzoprazole promotes gastric carcinogenesis in rats with duodenogastric reflux

被引：17

作者：

Viste A. ^{[1
]}

Øvrebø K. ^{[1
]}

Maartmann-Moe H. ^{[2
]}

Waldum H. ^{[3
]}

机构：

[1] Department of Surgery, Gade Institute, Haukeland University Hospital

[2] Department of Pathology, Haukeland University Hospital, Bergen

[3] Department of Medicine, NTNU, Trondheim

来源：

Gastric Cancer | 2004年 / 7卷 / 1期

关键词：

Carcinogenesis; Carcinoma; Duodenogastric reflux; Experimental; Proton pump inhibitors; Rat; Stomach;

D O I：

10.1007/s10120-003-0264-1

中图分类号：

学科分类号：

摘要：

Background. Duodenogastric reflux is known to cause an increased frequency of cancer in the glandular portion of the stomach in rats. Furthermore, it is debated whether inhibition of gastric acid secretion may promote gastric carcinogenesis. In the present study we examined the combined effect of gastroduodenal reflux and acid inhibition with respect to the development of gastric carcinoma in the rat. Methods. Following the construction of a gastrojejunostomy in male Wistar rats, half of them were given the proton pump inhibitor lanzoprazole for 1 year. The rats were then killed and the pH in the stomach and gastrin in blood were measured. The stomach was examined macroscopically as well as histologically. Results. Gastrin levels at autopsy were significantly increased in treated rats compared to the control group, confirming an effect of lanzoprazole on gastric acid secretion. Body weight was significantly reduced in the treated rats. Thirty of 79 rats developed gastric cancer, and they were all adenocarcinomas of the Lauren intestinal type. Gastric cancers occurred significantly more often in lanzoprazole-treated rats (50%) compared with controls (27%). Conclusion. Lanzoprazole given orally enhances the carcinogenic effect of duodenogastric reflux in rats.

引用

页码：31 / 35

页数：4

共 23 条

[1]

Waldum H.L., Brenna E., Personal review: Is profound acid inhibition safe?, Aliment Pharmacol Ther, 14, pp. 15-22, (2000)

[2]

Laine L., Ahnen D., McClain C., Solacia E., Walsh J.H., Potential gastrointestinal effects of long-term acid suppression with proton pump inhibitors, Aliment Pharmacol Ther, 14, pp. 651-668, (2000)

[3]

Wetscher G.J., Hinder R.A., Kretchmar D., Stinson R., Perdikis G., Smyrk T., Et al., Duodenogastric reflux causes growth stimulation of foregut mucosa potentiated by gastric acid blocade, Dig Dis Sci, 41, pp. 2166-2173, (1996)

[4]

Viste A., Bjornestad E., Opheim A., Skarstein A., Thunold J., Hartveit F., Et al., Risk of carcinoma following gastric operations for benign disease: A historical cohort study of 3470 patients, Lancet, 2, pp. 502-504, (1996)

[5]

Lundegardh G., Adami H.O., Hehnick C., Zack M., Meirik O., Stomach cancer after partial gastrectomy for benign ulcer disease, N Engl J Med, 319, pp. 195-200, (1988)

[6]

Miwa K., Hasegawa H., Fujimura T., Matsumoto H., Miyata R., Kosaka T., Et al., Duodenal reflux through the pylorus induces gastric adenocarcinoma in the rat, Carcinogenesis, 13, pp. 2313-2316, (1992)

[7]

Taylor P.R., Mason R.C., Filipe M.I., Vaja S., Hanley D.C., Murphy G.M., Et al., Gastric carcinogenesis in the rat induced by duodenogastric reflux without carcinogens: Morphology, mucin histochemistry, polyamine metabolism, and labelling index, Gut, 32, pp. 1447-1454, (1991)

[8]

Seven R., Mercan S., Ozarmagan S., Titiz I., Savci N., Dogan O., Nucleolar organizing regions in the operated rat stomach: Relationship to metaplasia, dysplasia and carcinoma, Br J Surg, 80, pp. 57-59, (1993)

[9]

Hortemo G.S., Maartmann-Moe H., Rokke O., Viste A., Effect of cimetidine on development of gastric cancer in rats after gastrojejunostomy, Eur J Surg, 165, pp. 259-261, (1999)

[10]

Wetscher G.J., Hinder R.A., Smyrk T., Perdikis G., Adrian T.E., Profanter C., Gastric acid blockade with omeprazole promotes gastric carcinogenesis induced by duodenogastric reflux, Dig Dis Sci, 44, pp. 1132-1135, (1999)

← 1 2 3 →